MedTrace Logo

Administration of Antioxidants to Infertile Men and Sperm Quality

NCT04256278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-04-19

No results posted yet for this study

Summary

The purpose of this randomized clinical trial is to assess the effect of oral antioxidant administration to infertile men, by evaluating semen variables, sperm DFI and levels of ROS. Oral antioxidants or placebo will be given for 3 consecutive months.

The study will recruit infertile men, who have one previous abnormal spermiogram, with at least one pathological variable (concentration, motility, morphology), according to WHO 2010 criteria. Participants will be recruited in the outpatient clinic of the Unit of Human Reproduction and of the Unit of Reproductive Endocrinology at the 1st Ob/Gyn Dept.

Conditions

  • Male Infertility

Interventions

OTHER

Spermotrend

oral administration of antioxidants for three months

Sponsors & Collaborators

  • Andrology lab Zeginiadou

    collaborator UNKNOWN

  • Armatura

    collaborator UNKNOWN

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Stratis Kolibianakis, Professor · Aristotle University Thessaloniki

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-28
Primary Completion
2022-04-29
Completion
2022-04-29

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04256278 on ClinicalTrials.gov